Recommendations on Minimal Residual Disease Monitoring in Acute Promyelocytic Leukemia Treated with Combination of All- Trans Retinoic Acid and Arsenic Trioxide
第一作者单位:[1]Shanghai Jiao Tong Univ, Shanghai Inst Hematol,Sch Med, Natl Res Ctr Translat Med Shanghai,Ruijin Hosp Af, State Key Lab Med Gen Natl Res Ctr Translat Med S, Shanghai, Peoples R China
推荐引用方式(GB/T 7714):
Chen Li,Zhu Hongming,Dong Fangyi,et al.Recommendations on Minimal Residual Disease Monitoring in Acute Promyelocytic Leukemia Treated with Combination of All- Trans Retinoic Acid and Arsenic Trioxide[J].BLOOD.2023,142:doi:10.1182/blood-2023-184433.
APA:
Chen, Li,Zhu, Hongming,Dong, Fangyi,Li, Yan,Liu, Qifa...&Li, Junmin.(2023).Recommendations on Minimal Residual Disease Monitoring in Acute Promyelocytic Leukemia Treated with Combination of All- Trans Retinoic Acid and Arsenic Trioxide.BLOOD,142,
MLA:
Chen, Li,et al."Recommendations on Minimal Residual Disease Monitoring in Acute Promyelocytic Leukemia Treated with Combination of All- Trans Retinoic Acid and Arsenic Trioxide".BLOOD 142.(2023)